Although identification of specific inhibitors against APOBEC3A and 3B are still ongoing, the development of APOBEC3A-ssDNA and APOBEC3B-ssDNA co-crystal structures may be helpful for developing structure-based molecule inhibitors that could be useful in cancer therapy [95,96]. Here, APOBEC3B is linked to cancer.